Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with primary advanced or recurrent endometrial carcinoma; use with carboplatin and paclitaxel followed by pembrolizumab alone.
LAMPGEN ANALYSIS
Why it matters
This chemoimmunotherapy indication covers the disease regardless of mismatch repair status, with results reported separately by MMR group.
What research teams should watch
Capture MMR results and use separate treatment phases to reconcile chemotherapy completion and maintenance exposure.
PRIMARY RECORDS